Screener
Cullinan Therapeutics, Inc. CGEM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $78,640 | $88,332 |
| Short-term investments | 255,898 | 289,564 |
| Prepaid expenses and other current assets | 7,436 | 8,860 |
| Total current assets | 341,974 | 386,756 |
| Property and equipment, net | 263 | 421 |
| Operating lease right-of-use assets | 2,233 | 2,630 |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s short-term investments?
- Cullinan Therapeutics, Inc. (CGEM) reported short-term investments of $255.9M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s short-term investments changed year-over-year?
- Cullinan Therapeutics, Inc.'s short-term investments increased by 32.8% year-over-year, from $192.66M to $255.9M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s short-term investments has grown at a 47.1% compound annual growth rate (CAGR), from $42.01M to $289.56M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Cullinan Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude